Next Generation Drug Conjugates Market Worth USD 7.94 Billion to 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Ambrx Biopharma Inc. (NYSE:AMAM) Given Consensus Rating of "Moderate Buy" by Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Solid Biosciences (NASDAQ:SLDB – Get Free Report) and Ambrx Biopharma (NYSE:AMAM – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, profitability and valuation. Profitability This table compares Solid Biosciences and […]
J&J to buy Shockwave for US$13B in medical device play bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
J&J has been rapidly building its portfolio in both medical technology and drug development to help prepare for the impending loss of exclusivity for Stelara, its top-selling drug for psoriasis, in the US next year.